US 8598203
Treatment of Crohn's disease with laquinimod
granted A61KA61K31/4704A61K31/519
Quick answer
US patent 8598203 (Treatment of Crohn's disease with laquinimod) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/4704, A61K31/519, A61K31/52, A61K31/573